Paper21079651
Role of NF-κB in the skeleton.
Novack DV. Cell Res, 2011. Cited by 284 papers, by iCite.
Cite this record
ConductScience Library. Role of NF-κB in the skeleton. Papers, record 21079651. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21079651
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bone and Bones | Major topic |
| NF-kappa B | Major topic |
| Animals | |
| Chondrocytes | |
| Mice | |
| Osteoblasts | |
| Osteoclasts | |
| Protein Subunits | |
| Signal Transduction |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AR052705 | NIAMS NIH HHS | United States | R01AR052705 | PubMed and NIH | NIH RePORTER |
| R21 EB007568 | NIBIB NIH HHS | United States | R21EB007568 | PubMed and NIH | NIH RePORTER |
| EB007568 | NIBIB NIH HHS | United States | R21EB007568 | PubMed and NIH | NIH RePORTER |
| AR052705 | NIAMS NIH HHS | United States | R01AR052705 | PubMed and NIH | NIH RePORTER |
| R21DK067689 | NIH | NIH RePORTER |
References99
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15252035 | The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis. | J Biol Chem | 2004 | https://conductscience.org/library/papers/15252035 | PubMed |
| 2 | 20199390 | NF-kappaB signaling: multiple angles to target OA. | Curr Drug Targets | 2010 | https://conductscience.org/library/papers/20199390 | PubMed |
| 3 | 12709443 | RelB/p50 dimers are differentially regulated by tumor necrosis factor-alpha and lymphotoxin-beta receptor activation: critical roles for p100. | J Biol Chem | 2003 | https://conductscience.org/library/papers/12709443 | PubMed |
| 4 | 19442620 | The bisphosphonate zoledronic acid decreases tumor growth in bone in mice with defective osteoclasts. | Bone | 2009 | https://conductscience.org/library/papers/19442620 | PubMed |
| 5 | 17516620 | A pilot study of tumor necrosis factor inhibition in erosive/inflammatory osteoarthritis of the hands. | J Rheumatol | 2007 | https://conductscience.org/library/papers/17516620 | PubMed |
| 6 | 20053716 | The estrogen receptor-alpha in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone. | Mol Endocrinol | 2010 | https://conductscience.org/library/papers/20053716 | PubMed |
| 7 | 20353839 | Activation of NF-kappaB by fluid shear stress, but not TNF-alpha, requires focal adhesion kinase in osteoblasts. | Bone | 2010 | https://conductscience.org/library/papers/20353839 | PubMed |
| 8 | 18567579 | Defective osteoclastogenesis by IKKbeta-null precursors is a result of receptor activator of NF-kappaB ligand (RANKL)-induced JNK-dependent apoptosis and impaired differentiation. | J Biol Chem | 2008 | https://conductscience.org/library/papers/18567579 | PubMed |
| 9 | 15485831 | Osteoclast differentiation is impaired in the absence of inhibitor of kappa B kinase alpha. | J Biol Chem | 2004 | https://conductscience.org/library/papers/15485831 | PubMed |
| 10 | 12670873 | A central role for the nuclear factor-kappaB pathway in anti-inflammatory and proinflammatory actions of mechanical strain. | FASEB J | 2003 | https://conductscience.org/library/papers/12670873 | PubMed |
| 11 | 17295604 | Effect of blockade of TNF-alpha and interleukin-1 action on bone resorption in early postmenopausal women. | J Bone Miner Res | 2007 | https://conductscience.org/library/papers/17295604 | PubMed |
| 12 | 12568403 | Expression of either NF-kappaB p50 or p52 in osteoclast precursors is required for IL-1-induced bone resorption. | J Bone Miner Res | 2003 | https://conductscience.org/library/papers/12568403 | PubMed |
| 13 | 17692805 | Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. | Cancer Cell | 2007 | https://conductscience.org/library/papers/17692805 | PubMed |
| 14 | 19858527 | Recent advances in understanding the molecular basis of Paget disease of bone. | J Clin Pathol | 2010 | https://conductscience.org/library/papers/19858527 | PubMed |
| 15 | 10637272 | Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. | J Exp Med | 2000 | https://conductscience.org/library/papers/10637272 | PubMed |
| 16 | 15880601 | Additive bone-protective effects of anabolic treatment when used in conjunction with RANKL and tumor necrosis factor inhibition in two rat arthritis models. | Arthritis Rheum | 2005 | https://conductscience.org/library/papers/15880601 | PubMed |
| 17 | 14612570 | Platelet and osteoclast beta3 integrins are critical for bone metastasis. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/14612570 | PubMed |
| 18 | 18382763 | Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice. | J Clin Invest | 2008 | https://conductscience.org/library/papers/18382763 | PubMed |
| 19 | 19270264 | Biologic sequelae of I{kappa}B kinase (IKK) inhibition in multiple myeloma: therapeutic implications. | Blood | 2009 | https://conductscience.org/library/papers/19270264 | PubMed |
| 20 | 20462435 | Biomechanical modulation of collagen fragment-induced anabolic and catabolic activities in chondrocyte/agarose constructs. | Arthritis Res Ther | 2010 | https://conductscience.org/library/papers/20462435 | PubMed |
Cited by194
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 284 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42751209 | Hydrogen releasing biomaterials for bone regeneration: mechanisms, design strategies, and applications. | Bioact Mater | 2027 | https://conductscience.org/library/papers/42751209 | PubMed |
| 42717193 | WDR23 prevents bone loss by promoting autophagic degradation of TRAF6 in osteoclastogenesis. | Bone Res | 2026 | https://conductscience.org/library/papers/42717193 | PubMed |
| 42658444 | A peroxiredoxin 1-reactive oxygen species feedback loop modulates nuclear factor kappa B activity in osteoclastogenesis. | Mol Biomed | 2026 | https://conductscience.org/library/papers/42658444 | PubMed |
| 42649114 | MPRO3 Regulates Macrophage Polarization and Osteoclastogenesis In Vitro and Attenuates Ligature-Induced Alveolar Bone Loss in Periodontitis. | J Microbiol Biotechnol | 2026 | https://conductscience.org/library/papers/42649114 | PubMed |
| 42598782 | Therapeutic Osteoinductive Potential of Saposhnikovia divaricata Schischkin in a Mouse Drill-Hole Bone Defect Model. | Adv Biol (Weinh) | 2026 | https://conductscience.org/library/papers/42598782 | PubMed |
| 42582789 | Molecular Mechanisms and Therapeutic Potential of Puerariae Lobatae Radix in Bone Metabolism: A Comprehensive Review. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/42582789 | PubMed |
| 42501125 | Differential Effects of a First-in-Class IKKα Inhibitor on Trabecular and Cortical Bone in a Human Prostate Cancer Xenograft Model. | Calcif Tissue Int | 2026 | https://conductscience.org/library/papers/42501125 | PubMed |
| 42393739 | Wubi Shanyao Pills ameliorate glucocorticoid-induced osteoporosis by regulating bone marrow T cell homing as an immune intermediate to restore bone metabolism. | Chin Med | 2026 | https://conductscience.org/library/papers/42393739 | PubMed |
| 42363259 | Dexamethasone reduces osteogenic potential through suppressing retinoic acid signaling via NF-κB/CYP26B1 axis in mesenchymal stem cells. | Stem Cell Res Ther | 2026 | https://conductscience.org/library/papers/42363259 | PubMed |
| 42244989 | Inhibition of SRC prevents bone metastasis of breast cancer by blocking metastatic cell motility and bone directionality. | Theranostics | 2026 | https://conductscience.org/library/papers/42244989 | PubMed |
| 42205009 | Blau syndrome initially presenting with hypercalcemia: a case report and literature review. | Ann Pediatr Endocrinol Metab | 2026 | https://conductscience.org/library/papers/42205009 | PubMed |
| 42198449 | MSC-Derived Apoptotic Vesicles Restore Bone Marrow Niche Homeostasis in Postmenopausal Osteoporosis by miRNA-Mediated Suppression of MAPK and NF-κB Signaling Nodes. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42198449 | PubMed |
| 42095446 | Sea Urchin-Inspired Immuno-Instructive Ionic Flow Drives MSCs-Macrophage Communication to Promote Bone Regeneration. | Adv Mater | 2026 | https://conductscience.org/library/papers/42095446 | PubMed |
| 42028630 | Anatomy changes, signalling pathways, and clinical treatment after ankle sprain. | Bone Joint Res | 2026 | https://conductscience.org/library/papers/42028630 | PubMed |
| 41854818 | Unveiling the multifaceted roles of BCL3: biological functions and disease implications. | Apoptosis | 2026 | https://conductscience.org/library/papers/41854818 | PubMed |
| 41852468 | The role and mechanisms of bone microenvironment regulators in osteoporosis: novel intervention strategies for addressing the challenges of aging. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/41852468 | PubMed |
| 41716342 | Biomaterial-assisted gene therapy for bone repair. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/41716342 | PubMed |
| 41622507 | Chrysin Exhibits Bone-Protective Effects Through Osteoclastogenesis Inhibition: In Vitro and In Vivo Evaluation in RAW 264.7 Murine Macrophages and Sprague-Dawley Rats. | Mol Nutr Food Res | 2026 | https://conductscience.org/library/papers/41622507 | PubMed |
| 41545352 | APEX1, a transcriptional hub for endochondral ossification and fracture repair. | Bone Res | 2026 | https://conductscience.org/library/papers/41545352 | PubMed |
| 41500539 | Interleukin-1β-induced arthritis involves chondrocyte oxiapoptophagy. | Korean J Physiol Pharmacol | 2026 | https://conductscience.org/library/papers/41500539 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21079651
GET https://conductscience.org/api/papers/v1/21079651/references?page=2